nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A New Model for Communicating Risk Information in Direct-to-Consumer Print Advertisements
|
Stotka, Jennifer L. |
|
|
41 |
1 |
p. 111-120 |
artikel |
2 |
Bayesian Data Mining Techniques: The Evidence Provided by Signals Detected in Single-Company Spontaneous Reports Databases
|
Cesana, Marina |
|
|
41 |
1 |
p. 11-21 |
artikel |
3 |
Consideration of Operational a Level with Different Approval Strategies
|
Zhen, Boguang Andy |
|
|
41 |
1 |
p. 23-29 |
artikel |
4 |
Continuous Marketing Applications: Experiences of Three Biotechnology Companies
|
Boisclair, Christine |
|
|
41 |
1 |
p. 101-109 |
artikel |
5 |
Effective Risk Management Tools
|
van der Velden, Jon Willem |
|
|
41 |
1 |
p. 63-68 |
artikel |
6 |
Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America
|
Offen, Walter |
|
|
41 |
1 |
p. 31-46 |
artikel |
7 |
RAMP (Risk Assessment and Management Process): An Approach to Risk-Based Computer System Validation and Part 11 Compliance
|
Siconolfi, Richard M. |
|
|
41 |
1 |
p. 69-79 |
artikel |
8 |
Risk Perception of Prescription Drugs: Results of a National Survey
|
Slovic, Paul |
|
|
41 |
1 |
p. 81-100 |
artikel |
9 |
The Choice of Two Baselines
|
Bristol, David R. |
|
|
41 |
1 |
p. 57-61 |
artikel |
10 |
The Drug Information Journal and the Drug Information Association
|
Hamrell, Michael R. |
|
|
41 |
1 |
p. xi |
artikel |
11 |
The Probability of Observing Negative Subgroup Results When the Treatment Effect is Positive and Homogeneous across All Subgroups
|
Li, Zhengqing |
|
|
41 |
1 |
p. 47-56 |
artikel |
12 |
Unwanted Immunogenicity: Implications for Follow-on Biologicals
|
Wadhwa, Meenu |
|
|
41 |
1 |
p. 1-9 |
artikel |